Akgül Sinem, Kanbur Nuray, Güçer Safak, Safak Tunc, Derman Orhan
Division of Adolescent Medicine, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
J Pediatr Endocrinol Metab. 2012;25(7-8):753-5. doi: 10.1515/jpem-2012-0105.
Pubertal gynecomastia is the glandular proliferation of male breast tissue. It is regarded as a physiological phenomenon, arising due to a presumed transient imbalance in the ratio of free androgen to free estrogen. Treatment with tamoxifen, a selective estrogen receptor blocker, has been shown to effectively reduce the disc size and is generally considered for treatment when the disc diameter is > 3-4 cm. For severe or persistent cases, surgery is considered the mainstay of treatment. We present three cases who reported dissatisfaction with the results of tamoxifen treatment and were therefore submitted to adenectomy by Webster's technique preceded by liposuction. Pathology results showed adipose tissue alone, with no evidence of intraductal epithelial proliferation. The results showing a lack of residual glandular breast tissue after treatment using tamoxifen proves that it is effective in histopathologically eliminating pubertal gynecomastia.
青春期男性乳房肥大是男性乳腺组织的腺体增生。它被视为一种生理现象,其发生是由于游离雄激素与游离雌激素的比例可能出现短暂失衡。他莫昔芬是一种选择性雌激素受体阻滞剂,已证明用其治疗可有效减小乳房尺寸,当乳房直径>3 - 4厘米时,通常会考虑用其进行治疗。对于严重或持续性病例,手术被认为是主要的治疗方法。我们报告了三例患者,他们对他莫昔芬治疗的结果不满意,因此在吸脂后采用韦伯斯特技术进行了乳腺切除术。病理结果显示仅为脂肪组织,没有导管内上皮增生的证据。结果表明,使用他莫昔芬治疗后缺乏残留的乳腺腺体组织,证明其在组织病理学上消除青春期男性乳房肥大是有效的。